copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer.
<h4>Background</h4>Inherited factors predisposing individuals to breast and ovarian cancer are largely unidentified in a majority of families with hereditary breast and ovarian cancer (HBOC). We aimed to identify germline copy number variations (CNVs) contributing to HBOC susceptibility...
Guardado en:
Autores principales: | Kirsi M Kuusisto, Oyediran Akinrinade, Mauno Vihinen, Minna Kankuri-Tammilehto, Satu-Leena Laasanen, Johanna Schleutker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4842ef037dbe436a9fc91a1bc1c7d1af |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
por: Olga Kondrashova, et al.
Publicado: (2018) -
Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations.
por: Nicolai Juul Birkbak, et al.
Publicado: (2013) -
Copy number variation in Thai population.
por: Bhoom Suktitipat, et al.
Publicado: (2014) -
Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
por: Ana Blanco, et al.
Publicado: (2013) -
Pan-cancer analysis of neoepitopes
por: Gabriel N. Teku, et al.
Publicado: (2018)